Advertisement

MR Imaging of Epithelial Ovarian Neoplasms Part I: Benign and Borderline

Published:October 20, 2022DOI:https://doi.org/10.1016/j.mric.2022.06.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Magnetic Resonance Imaging Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McDonald J.M.
        • Modesitt S.C.
        The incidental postmenopausal adnexal mass.
        Clin Obstet Gynecol. 2006; 49: 506-516
        • Naqvi J.
        • Nagaraju E.
        • Ahmad S.
        MRI appearances of pure epithelial papillary serous borderline ovarian tumours.
        Clin Radiol. 2015; 70: 424-432
        • Koonings P.P.
        • Campbell K.
        • Mishell Jr., D.R.
        • et al.
        Relative frequency of primary ovarian neoplasms: a 10-year review.
        Obstet Gynecol. 1989; 74: 921-926
        • Hauptmann S.
        • Friedrich K.
        • Redline R.
        • et al.
        Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
        Virchows Arch. 2017; 470: 125-142
        • Cheung A.
        • Ellenson L.H.
        • Gilks C.B.
        WHO classification of tumours: female genital tumours.
        5th edition. International Agency for Research on Cancer, 2020
        • Iyer V.R.
        • Lee S.I.
        MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.
        AJR Am J Roentgenol. 2010; 194: 311-321
        • Tanaka Y.O.
        • Okada S.
        • Satoh T.
        • et al.
        Ovarian serous surface papillary borderline tumors form sea anemone-like masses.
        J Magn Reson Imaging. 2011; 33: 633-640
        • Kurman R.J.
        • Shih Ie M.
        Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.
        Int J Gynecol Pathol. 2008; 27: 151-160
        • Jung S.E.
        • Lee J.M.
        • Rha S.E.
        • et al.
        CT and MR imaging of ovarian tumors with emphasis on differential diagnosis.
        Radiographics. 2002; 22: 1305-1325
        • Vargas H.A.
        • Barrett T.
        • Sala E.
        MRI of ovarian masses.
        J Magn Reson Imaging. 2013; 37: 265-281
        • Griffin N.
        • Grant L.A.
        • Sala E.
        Adnexal masses: characterization and imaging strategies.
        Semin Ultrasound CT MR. 2010; 31: 330-346
        • Folkins A.K.
        • Longacre T.A.
        Low-grade Serous Neoplasia of the Female Genital Tract.
        Surg Pathol Clin. 2019; 12: 481-513
        • Khati N.J.
        • Kim T.
        • Riess J.
        Imaging of Benign Adnexal Disease.
        Radiol Clin North Am. 2020; 58: 257-273
        • Tang Y.Z.
        • Liyanage S.
        • Narayanan P.
        • et al.
        The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns.
        Eur Radiol. 2013; 23: 48-56
        • Shimizu S.
        • Okano H.
        • Ishitani K.
        • et al.
        Ovarian cystadenofibroma with solid nodular components masqueraded as ovarian cancer.
        Arch Gynecol Obstet. 2009; 279: 709-711
        • Khashper A.
        • Addley H.C.
        • Abourokbah N.
        • et al.
        T2-hypointense adnexal lesions: an imaging algorithm.
        Radiographics. 2012; 32: 1047-1064
        • Flicek K.T.
        • VanBuren W.
        • Dudiak K.
        • et al.
        Borderline epithelial ovarian tumors: what the radiologist should know.
        Abdom Radiol (Ny). 2021; 46: 2350-2366
        • Mayr D.
        • Hirschmann A.
        • Löhrs U.
        • et al.
        KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
        Gynecol Oncol. 2006; 103: 883-887
        • Zhao S.H.
        • Qiang J.W.
        • Zhang G.F.
        • et al.
        MRI appearances of ovarian serous borderline tumor: pathological correlation.
        J Magn Reson Imaging. 2014; 40: 151-156
        • Thomassin-Naggara I.
        • Balvay D.
        • Aubert E.
        • et al.
        Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
        Eur Radiol. 2012; 22: 738-745
        • Seidman J.D.
        • Horkayne-Szakaly I.
        • Haiba M.
        • et al.
        The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin.
        Int J Gynecol Pathol. 2004; 23: 41-44
        • Tropé C.G.
        • Kaern J.
        • Davidson B.
        Borderline ovarian tumours.
        Best Pract Res Clin Obstet Gynaecol. 2012; 26: 325-336
        • Prat J.
        • D'Angelo E.
        • Espinosa I.
        Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.
        Hum Pathol. 2018; 80: 11-27
        • Garrett A.P.
        • Lee K.R.
        • Colitti C.R.
        • et al.
        k-ras mutation may be an early event in mucinous ovarian tumorigenesis.
        Int J Gynecol Pathol. 2001; 20: 244-251
        • Duska L.R.
        • Kohn E.C.
        The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.
        Ann Oncol. 2017; 28 (viii8-viii12)
        • Kurman RJ C.M.
        • Herrington C.S.
        • Young R.H.
        WHO classification of Tumours of Female Reproductive Organs. 4th edition. Lyon: International Agency for Research on Cancer, France2014
        • Mills A.M.
        • Shanes E.D.
        Mucinous Ovarian Tumors.
        Surg Pathol Clin. 2019; 12: 565-585
        • Dhanda S.
        • Thakur M.
        • Kerkar R.
        • et al.
        Diffusion-weighted imaging of gynecologic tumors: diagnostic pearls and potential pitfalls.
        Radiographics. 2014; 34: 1393-1416
        • Taylor E.C.
        • Irshaid L.
        • Mathur M.
        Multimodality Imaging Approach to Ovarian Neoplasms with Pathologic Correlation.
        Radiographics. 2021; 41: 289-315
        • Ohya A.
        • Ichinohe F.
        • Matoba H.
        • et al.
        Useful preoperative examination findings to classify the grade of ovarian primary mucinous tumor.
        Abdom Radiol (Ny). 2021; 46: 2393-2402
        • Abdel Wahab C.
        • Rousset P.
        • Bolze P.A.
        • et al.
        [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
        Gynecol Obstet Fertil Senol. 2020; 48: 260-276
        • Peng Y.
        • Lin J.
        • Guan J.
        • et al.
        Ovarian collision tumors: imaging findings, pathological characteristics, diagnosis, and differential diagnosis.
        Abdom Radiol (Ny). 2018; 43: 2156-2168
        • Dimova J.
        • Zlatareva D.
        • Bakalova R.
        • et al.
        Adnexal masses characterized on 3 tesla magnetic resonance imaging - added value of diffusion techniques.
        Radiol Oncol. 2020; 54: 419-428
        • Woodruff J.D.
        • Dietrich D.
        • Genadry R.
        • et al.
        Proliferative and malignant Brenner tumors. Review of 47 cases.
        Am J Obstet Gynecol. 1981; 141: 118-125
        • Montoriol P.F.
        • Hordonneau C.
        • Boudinaud C.
        • et al.
        Benign Brenner tumour of the ovary: CT and MRI features.
        Clin Radiol. 2021; 76: 593-598
        • Takahama J.
        • Ascher S.M.
        • Hirohashi S.
        • et al.
        Borderline Brenner tumor of the ovary: MRI findings.
        Abdom Imaging. 2004; 29: 528-530
        • Ricotta G.
        • Maulard A.
        • Genestie C.
        • et al.
        Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
        Ann Surg Oncol. 2021; 28: 6714-6720
        • Yin Z.
        • Peters S.
        • Chokshi R.
        • et al.
        Ovarian Clear Cell Adenofibroma of Low Malignant Potential Developing Into Clear Cell Adenocarcinoma.
        Int J Surg Pathol. 2018; 26: 578-580
        • Takeuchi M.
        • Matsuzaki K.
        • Uehara H.
        • et al.
        Clear cell adenocarcinoma arising from clear cell adenofibroma of the ovary: value of DWI and DCE-MRI.
        Magn Reson Med Sci. 2013; 12: 305-308
        • Ricotta G.
        • Maulard A.
        • Candiani M.
        • et al.
        Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management.
        Ann Surg Oncol. 2022; 29: 1165-1170
        • Nagamine M.
        • Mikami Y.
        Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues.
        Diagnostics (Basel). 2020; 10
        • Kurata Y.
        • Kido A.
        • Moribata Y.
        • et al.
        Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
        Magn Reson Med Sci. 2018; 17: 211-217
        • Bell D.A.
        • Scully R.E.
        Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases.
        Am J Surg Pathol. 1985; 9: 205-214
        • Matias-Guiu X.
        • Stewart C.J.R.
        Endometriosis-associated ovarian neoplasia.
        Pathology. 2018; 50: 190-204
        • Nakagawa E.
        • Abiko K.
        • Kido A.
        • et al.
        Four cases of endometrioid borderline ovarian tumour: case reports and literature review.
        BJR Case Rep. 2018; 4: 20170062
        • Kommoss F.
        • Gilks C.B.
        Pathology of Ovarian Cancer: Recent Insights Unveiling Opportunities in Prevention.
        Clin Obstet Gynecol. 2017; 60: 686-696
        • Brun J.L.
        • Fritel X.
        • Aubard Y.
        • et al.
        Management of presumed benign ovarian tumors: updated French guidelines.
        Eur J Obstet Gynecol Reprod Biol. 2014; 183: 52-58
        • Beroukhim G.
        • Ozgediz D.
        • Cohen P.J.
        • et al.
        Progression of Cystadenoma to Mucinous Borderline Ovarian Tumor in Young Females: Case Series and Literature Review.
        J Pediatr Adolesc Gynecol. 2021; 35: 359-367
        • Brown J.
        • Frumovitz M.
        Mucinous tumors of the ovary: current thoughts on diagnosis and management.
        Curr Oncol Rep. 2014; 16: 389
        • Bourdel N.
        • Huchon C.
        • Abdel Wahab C.
        • et al.
        Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
        Eur J Obstet Gynecol Reprod Biol. 2021; 256: 492-501
        • Chevrot A.
        • Pouget N.
        • Bats A.S.
        • et al.
        Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
        Gynecol Oncol. 2020; 157: 29-35
        • Patrono M.G.
        • Minig L.
        • Diaz-Padilla I.
        • et al.
        Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment.
        Ecancermedicalscience. 2013; 7: 379
        • Vasconcelos I.
        • de Sousa Mendes M.
        Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
        Eur J Cancer. 2015; 51: 620-631
        • Daraï E.
        • Fauvet R.
        • Uzan C.
        • et al.
        Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.
        Hum Reprod Update. 2013; 19: 151-166
        • Palomba S.
        • Falbo A.
        • Del Negro S.
        • et al.
        Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up.
        Hum Reprod. 2010; 25: 1966-1972
        • deSouza N.M.
        • O'Neill R.
        • McIndoe G.A.
        • et al.
        Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease.
        AJR Am J Roentgenol. 2005; 184: 999-1003
        • Acs G.
        Serous and mucinous borderline (low malignant potential) tumors of the ovary.
        Am J Clin Pathol. 2005; 123: S13-S57
        • Chen V.W.
        • Ruiz B.
        • Killeen J.L.
        • et al.
        Pathology and classification of ovarian tumors.
        Cancer. 2003; 97: 2631-2642
        • Cadron I.
        • Leunen K.
        • Van Gorp T.
        • et al.
        Management of borderline ovarian neoplasms.
        J Clin Oncol. 2007; 25: 2928-2937
        • Alvarez R.M.
        • Vazquez-Vicente D.
        Fertility sparing treatment in borderline ovarian tumours.
        Ecancermedicalscience. 2015; 9: 507
        • Lenhard M.S.
        • Mitterer S.
        • Kümper C.
        • et al.
        Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort.
        Eur J Obstet Gynecol Reprod Biol. 2009; 145: 189-194
        • Feigenberg T.
        • Covens A.
        • Ghorab Z.
        • et al.
        Is routine appendectomy at the time of primary surgery for mucinous ovarian neoplasms beneficial?.
        Int J Gynecol Cancer. 2013; 23: 1205-1209
        • McEvoy S.H.
        • Nougaret S.
        • Abu-Rustum N.R.
        • et al.
        Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.
        Abdom Radiol (Ny). 2017; 42: 2488-2512
        • Alves A.S.
        • Félix A.
        • Cunha T.M.
        Clues to the diagnosis of borderline ovarian tumours: An imaging guide.
        Eur J Radiol. 2021; 143109904
        • Lesieur B.
        • Kane A.
        • Duvillard P.
        • et al.
        Prognostic value of lymph node involvement in ovarian serous borderline tumors.
        Am J Obstet Gynecol. 2011; 204 (438.e431-437)
      1. NCCN Guideline for Patients Ovarian Cancer.
        (Available at:) (Accessed March 25 2022)